CPT® Code 87516

The CPT® Code 87516 refers to a laboratory test specifically designed for the detection of the hepatitis B virus (HBV) through the analysis of nucleic acids, which can be either DNA or RNA. This test employs an amplified probe technique, which enhances the sensitivity and specificity of the detection process. Hepatitis B is a significant public health concern, as chronic infection with this virus can lead to severe liver complications, including cirrhosis and hepatocellular carcinoma, a type of liver cancer. The virus is primarily transmitted through blood and body fluids, making it crucial for individuals at risk, such as those with multiple sexual partners or those who share needles, to undergo regular testing. The procedure involves obtaining a blood sample from the patient, which is then processed to extract serum or plasma for testing. The amplified probe technique utilized in this test involves real-time polymerase chain reaction (RT-PCR), a method that replicates specific strands of HBV DNA or RNA. This replication process allows for the identification of the viral genetic material using DNA probes that are tagged with fluorescent or chemiluminescent markers, ensuring that only the target sequences are detected. The sensitivity of this test is notable, as it can identify HBV nucleic acid even at low viral loads, as minimal as 20 IU/mL (116 copies/mL). The presence of HBV DNA or RNA in the sample indicates active viral replication, which is critical for diagnosing and managing HBV infections. Furthermore, this test can provide valuable prognostic information, especially in cases where hepatitis B surface Antigen (HBsAg) is negative. For more comprehensive assessment, CPT® Code 87517 is utilized for quantifying HBV DNA or RNA, allowing healthcare providers to monitor the viral load, which is essential for evaluating disease progression and the effectiveness of treatment regimens.